Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Maria Schwaederle

Actionability and precision oncology

scientific article published on 12 September 2015

An appraisal of drug development timelines in the Era of precision oncology

scientific article published on 13 July 2016

Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis

scientific article

Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics

scientific article

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics

scientific article

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

scientific article published on February 2016

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications

scientific article (publication date: September 2015)

Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing

scientific article published on 14 August 2017

Genomic landscape of salivary gland tumors

scientific article

HER2 expression status in diverse cancers: review of results from 37,992 patients

scientific article

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

scientific article published on 24 August 2015

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval

scientific article published on 15 September 2015

K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo ⬇️

scientific article published on August 31, 2012

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.

scientific article published on 4 June 2018

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology

scientific article published on 16 September 2015

Molecular tumor board: the University of California-San Diego Moores Cancer Center experience

scientific article

Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer

scientific article

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients

scientific article published on 7 April 2015

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

scientific article

Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types

scientific article

TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [18F] fluorodeoxyglucose (18F-FDG PET).

scientific article

Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients

scientific article

Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients

scientific article published on 17 July 2017

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms

scientific article

Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients

scientific article published on 16 May 2016

Paulina is supported by:

About Paulina

Help